Precision medicine
The aim of the partnership is to research how AI can help predict cancer progression.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.
Around two in five Malaysians are said to have metabolic syndrome.
Also, Indian diagnostics chain Redcliffe Labs has rolled out a mobile diabetes risk calculation feature.
They will collaborate on identifying novel therapeutic drug candidates for lung cancer.
The tech aims to deliver AI-driven drug response prediction to human oncology.
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
Also, a Hong Kong project has received $5 million in funding to develop LLM-run companion robots for the mentally underserved.
Also, Monash University researchers have made it possible to do an MRI scan in five minutes using AI.
The precision health company will help introduce Neurable's neurotechnology into clinics globally to help providers measure individuals' brain health.